# Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats

> **NCT06491394** · PHASE4 · COMPLETED · sponsor: **Aswan University Hospital** · enrollment: 24 (actual)

## Conditions studied

- Rhabdomyolysis

## Interventions

- **DRUG:** Lactoferrin
- **DIAGNOSTIC_TEST:** iron
- **DIAGNOSTIC_TEST:** MDA, TAC, and GSH
- **DIAGNOSTIC_TEST:** Nrf2
- **DIAGNOSTIC_TEST:** AMPK
- **DIAGNOSTIC_TEST:** HO-1
- **DRUG:** glycerin

## Key facts

- **NCT ID:** NCT06491394
- **Lead sponsor:** Aswan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06491394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06491394, "Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06491394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*